As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

During oral arguments, the defendants contended that the plaintiffs could not support their allegations that Novo Nordisk and ...

Significant weight gain is a common side effect of many psychiatric medications. Fortunately, there are options for those who ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, has shown positive Phase 3 results in treating type 2 ...

Terns Pharmaceuticals, Inc.’s TERN share price has surged by 5.83%, which has investors questioning if this is right time to ...

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid ...